Carenzi A - Search Results

1

Evidence for a different sensitivity to various central effects of interleukin-1 beta in mice.

Masotto C, Caspani G, De Simoni MG, Mengozzi M, Scatturin M, Sironi M, Carenzi A, Ghezzi P. Masotto C, et al. Among authors: carenzi a. Brain Res Bull. 1992 Feb;28(2):161-5. doi: 10.1016/0361-9230(92)90175-w. Brain Res Bull. 1992. PMID: 1596738

2

n-hexane induces parkinsonism in rodents.

Pezzoli G, Ricciardi S, Masotto C, Mariani CB, Carenzi A. Pezzoli G, et al. Among authors: carenzi a. Brain Res. 1990 Oct 29;531(1-2):355-7. doi: 10.1016/0006-8993(90)90801-h. Brain Res. 1990. PMID: 1705155

3

Influence of opioids on beta-receptors down-regulation: studies in cultured C6 glioma cells.

Reggiani A, Carenzi A, Della Bella D. Reggiani A, et al. Among authors: carenzi a. Brain Res. 1987 Oct 13;423(1-2):254-60. doi: 10.1016/0006-8993(87)90847-x. Brain Res. 1987. PMID: 2823987

4

Opioids and beta-receptors interaction: further studies in cultured cells.

Reggiani A, Carenzi A, Bella DD. Reggiani A, et al. Among authors: carenzi a. NIDA Res Monogr. 1986;75:347-50. NIDA Res Monogr. 1986. PMID: 2828983

5

The specific binding of broxaterol, a new beta 2-selective agonist, to beta-adrenoceptors.

Sala R, Moriggi E, Della Bella D, Carenzi A. Sala R, et al. Among authors: carenzi a. Eur J Pharmacol. 1991 Oct 2;203(1):17-23. doi: 10.1016/0014-2999(91)90785-o. Eur J Pharmacol. 1991. PMID: 1686765

6

N-(4-Isoxazolylthiazol-2-yl)oxamic acid derivatives as potent orally active antianaphylactic agents.

Chiarino D, Grancini G, Frigeni V, Biasini I, Carenzi A. Chiarino D, et al. Among authors: carenzi a. J Med Chem. 1991 Feb;34(2):600-5. doi: 10.1021/jm00106a020. J Med Chem. 1991. PMID: 1899891

7

New isoxazole derivatives provided with antihypertensive activity.

Carenzi A, Chiarino D, Napoletano M, Reggiani A, Sala A, Sala R. Carenzi A, et al. Arzneimittelforschung. 1989 Jun;39(6):642-6. doi: 10.1002/chin.198948203. Arzneimittelforschung. 1989. PMID: 2775328

8

Synthesis and in vitro antibacterial properties of 2-(3-bromo-5-isoxazolylideneamino-oxy)acetamido-beta-lactam derivatives.

Sala A, Chiarino D, Napoletano M, Albini E, Carenzi A. Sala A, et al. Among authors: carenzi a. Farmaco. 1991 Jul-Aug;46(7-8):887-97. Farmaco. 1991. PMID: 1793473

9

Intraventricular infusion of epidermal growth factor restores dopaminergic pathway in hemiparkinsonian rats.

Pezzoli G, Zecchinelli A, Ricciardi S, Burke RE, Fahn S, Scarlato G, Carenzi A. Pezzoli G, et al. Among authors: carenzi a. Mov Disord. 1991;6(4):281-7. doi: 10.1002/mds.870060403. Mov Disord. 1991. PMID: 1684638

10

Methionine-enkephalin, substance P, and homovanillic acid in the CSF of parkinsonian patients.

Pezzoli G, Panerai AE, Di Giulio A, Longo A, Passerini D, Carenzi A. Pezzoli G, et al. Among authors: carenzi a. Neurology. 1984 Apr;34(4):516-9. doi: 10.1212/wnl.34.4.516. Neurology. 1984. PMID: 6199690

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

40 results

Search Page

Filters